drugset / Trial / NCT00378560
V501 Efficacy Study in Women Aged 18 to 26 (V501-027)
RandomizedParallel-groupDouble-blindPrevention
Summary
A study to evaluate the efficacy, immunogenicity, safety and tolerability of V501 in adult women
Timeline
- Start
- 2006-06-12
- Primary completion
- 2009-09-16
- Completion
- 2009-09-16
Publications
- Results Yoshikawa H, Ebihara K, Tanaka Y, Noda K. Efficacy of quadrivalent human papillomavirus (types 6, 11, 16 and 18) vaccine (GARDASIL) in Japanese women aged 18-26 years. Cancer Sci. 2013 Apr;104(4):465-72. doi: 10.1111/cas.12106. Epub 2013 Mar 7.
- Murata S, Shirakawa M, Sugawara Y, Shuto M, Sawata M, Tanaka Y. Post-hoc analysis of injection-site reactions following vaccination with quadrivalent human papillomavirus vaccine in Japanese female clinical trial participants. Papillomavirus Res. 2020 Dec;10:100205. doi: 10.1016/j.pvr.2020.100205. Epub 2020 Aug 19.
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Gardasil | Vaccine | 0.5 ml | Other |